Improving Expression and Manufacturing of Novel BiologicsImproving Expression and Manufacturing of Novel Biologics

This panel features BioProcess Insider editor Millie Nelson moderating a panel discussion with Larry Forman (chief executive officer (CEO) of cell-line engineering company CHO Plus), Nathan Lewis (professor of pediatrics and bioengineering at the University of California in San Diego, UCSD), and Steve McCloskey (CEO of Nanome).

Register or Login and hit Watch on Demand to view the recorded panel discussion now.